Skip to main content
OpenTrials

Clinical trial condition

Haematologic Neoplasms

Explore clinical trials studying Haematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Haematologic Neoplasms trial results

Recruiting

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

NCT07064122

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Research Site Miami, Florida, United States
  • Research Site Tampa, Florida, United States
  • Research Site Houston, Texas, United States
  • Research Site Heidelberg, Australia
View all 21 locations
View Trial Details

Related conditions